Corti A - Search Results

1

Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged Nanogold.

Gasparri AM, Sacchi A, Basso V, Cortesi F, Freschi M, Rrapaj E, Bellone M, Casorati G, Dellabona P, Mondino A, Corti A, Curnis F. Gasparri AM, et al. Among authors: corti a. Small. 2019 Nov;15(45):e1903462. doi: 10.1002/smll.201903462. Epub 2019 Sep 16. Small. 2019. PMID: 31523920

2

Characterisation of circulating chromogranin A in human cancer patients.

Corti A, Gasparri A, Chen FX, Pelagi M, Brandazza A, Sidoli A, Siccardi AG. Corti A, et al. Br J Cancer. 1996 Apr;73(8):924-32. doi: 10.1038/bjc.1996.183. Br J Cancer. 1996. PMID: 8611427 Free PMC article.

3

Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains.

Corti A, Longhi R, Gasparri A, Chen F, Pelagi M, Siccardi AG. Corti A, et al. Eur J Biochem. 1996 Jan 15;235(1-2):275-80. doi: 10.1111/j.1432-1033.1996.00275.x. Eur J Biochem. 1996. PMID: 8631342 Free article.

4

Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha.

Moro M, Pelagi M, Fulci G, Paganelli G, Dellabona P, Casorati G, Siccardi AG, Corti A. Moro M, et al. Among authors: corti a. Cancer Res. 1997 May 15;57(10):1922-8. Cancer Res. 1997. PMID: 9157986

5

Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain.

Gasparri A, Sidoli A, Sanchez LP, Longhi R, Siccardi AG, Marchisio PC, Corti A. Gasparri A, et al. Among authors: corti a. J Biol Chem. 1997 Aug 15;272(33):20835-43. doi: 10.1074/jbc.272.33.20835. J Biol Chem. 1997. PMID: 9252409 Free article.

6

Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) -- evidence of dimer-monomer equilibria.

Corti A, Sanchez LP, Gasparri A, Curnis F, Longhi R, Brandazza A, Siccardi AG, Sidoli A. Corti A, et al. Eur J Biochem. 1997 Sep 15;248(3):692-9. doi: 10.1111/j.1432-1033.1997.00692.x. Eur J Biochem. 1997. PMID: 9342219 Free article.

7

Tumor targeting with biotinylated tumor necrosis factor alpha: structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.

Corti A, Gasparri A, Sacchi A, Curnis F, Sangregorio R, Colombo B, Siccardi AG, Magni F. Corti A, et al. Cancer Res. 1998 Sep 1;58(17):3866-72. Cancer Res. 1998. PMID: 9731496

8

Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.

Moro M, Gasparri AM, Pagano S, Bellone M, Tornaghi P, Veglia F, Corti A, Casorati G, Dellabona P. Moro M, et al. Among authors: corti a. Cancer Res. 1999 Jun 1;59(11):2650-6. Cancer Res. 1999. PMID: 10363988

9

Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.

Gasparri A, Moro M, Curnis F, Sacchi A, Pagano S, Veglia F, Casorati G, Siccardi AG, Dellabona P, Corti A. Gasparri A, et al. Among authors: corti a. Cancer Res. 1999 Jun 15;59(12):2917-23. Cancer Res. 1999. PMID: 10383155

10

Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer.

Dellabona P, Moro M, Crosti MC, Casorati G, Corti A. Dellabona P, et al. Among authors: corti a. Gene Ther. 1999 Feb;6(2):153-4. doi: 10.1038/sj.gt.3300829. Gene Ther. 1999. PMID: 10435097 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters